Neuroscience
Adrenoleukodystrophy
73%
Leukodystrophy
49%
Diffusion Tensor Imaging
47%
Magnetic Resonance Imaging
41%
Cerebral Palsy
38%
Ischemia
38%
Corpus Callosum
35%
In Vivo
29%
Magnetic Resonance Imaging
29%
Magnetization Transfer
28%
Brain Ischemia
27%
Hypothermia
26%
Exome Sequencing
25%
Fractional Anisotropy
25%
Stem Cell
23%
Pervasive Developmental Disorder
22%
Neurodevelopmental Disorder
22%
Neurological Disorder
17%
Nervous System Disorder
17%
Choline
17%
Central Nervous System
15%
Krabbe Disease
14%
Anterior Commissure
14%
AMPA Receptor
14%
Neuroprotection
14%
Placebo
14%
Leukoencephalopathy
13%
Expanded Disability Status Scale
13%
Ataxia
12%
Hypoplasia
12%
Progenitor Cell
12%
Cognitive Disorders
12%
Oligodendrocyte Progenitor
11%
Myelinogenesis
11%
Oligodendrocyte
11%
In Vitro
11%
Meta-Analysis
11%
Synapse
10%
Metabolic Pathway
10%
Cell Death
10%
White Matter Disease
10%
Dystonia
10%
Glutamic Acid
10%
Very Long Chain Fatty Acid
10%
Gene Expression
9%
Epileptic Absence
9%
CRISPR
8%
Cell Therapy
8%
Mesenchymal Stem Cell
8%
Brainstem
8%
Keyphrases
Adrenoleukodystrophy
69%
X-linked Adrenoleukodystrophy (X-ALD)
60%
Cerebral Palsy
47%
Leukodystrophy
44%
Adrenomyeloneuropathy
42%
Diffusion Tensor Imaging
36%
Intellectual Disability
35%
Hypoxic-ischemic Encephalopathy
33%
Fractional Anisotropy
22%
Newborn Screening
21%
Cerebellar Hypoplasia
21%
Hypothermia
18%
Neurodevelopmental Disorders
17%
Corticospinal Tract
17%
Hematopoietic Stem Cell Transplantation
17%
Epilepsy
16%
Long-chain Polyunsaturated Fatty Acids (LC-PUFA)
16%
Dendrimer
16%
Hypoxia-ischemia
15%
Autism Spectrum Disorder
15%
Spinal Cord
15%
Mouse Model
15%
Developmental Delay
15%
Seizure
14%
Dysmorphism
14%
Leukoencephalopathy
14%
Sex-dependent
14%
Consensus Statement
14%
Neuritogenesis
14%
Consensus-based
14%
WDR37
14%
Glial Precursor
14%
Coloboma
14%
Rivoglitazone
14%
Neurological Disorders
13%
Perinatal White Matter Injury
13%
Periventricular Leukomalacia
13%
Magnetization Transfer
13%
Neuroinflammation
12%
Therapeutic Strategies
11%
Brain Injury
11%
Whole Exome Sequencing
11%
Polyamidoamine (PAMAM)
10%
White Matter Integrity
10%
Disease Progression
10%
AMPA Receptor (AMPAR)
10%
Caregivers
10%
CD-1 Mice
10%
Neurological Diseases
10%
Nervous System
10%
Medicine and Dentistry
Adrenoleukodystrophy
100%
Disease
64%
Leukodystrophy
43%
Spastic Diplegia
34%
Magnetic Resonance Imaging
27%
Ischemia
24%
Disease Exacerbation
22%
Newborn Screening
22%
Developmental Delay
22%
Diagnosis
21%
Brain Injury
21%
Dendrimer
19%
Hematopoietic Stem Cell Transplantation
17%
Metachromatic Leukodystrophy
15%
Brain Disease
14%
Injury
14%
Leukoencephalopathy
14%
Hypothermia
14%
Encephalomalacia
14%
Exome Sequencing
14%
Symptom
13%
Hypoxic-Ischemic Encephalopathy
13%
Clinical Trial
13%
Stem Cell
12%
Pathophysiology
12%
Hypotonia
11%
Biological Marker
11%
Pervasive Developmental Disorder
11%
Microglia
11%
Clinician
11%
Placebo
10%
Oligodendrocyte
10%
Neurologic Disease
10%
Genetic Disorder
10%
Cognitive Defect
9%
Antioxidant
9%
Mesenchymal Stem Cell
9%
Cord Blood
9%
Very Long Chain Fatty Acid
9%
Neuroinflammation
8%
Pediatrics
8%
Progenitor Cell
8%
Acetic Acid Derivative
8%
Genotype Phenotype Correlation
8%
Neuroprotection
8%
Cysteine
8%
Drug Therapy
7%
Clinical Feature
7%
ABCD1
7%
Lip
7%
